Willam Kelley Insider Profile
4 Followers
Willam Kelley, Director at Merck & Company, holds 90.74K shares in Asensus Surgical (Ticker: ASXC), holds 75.50K shares in GenVec Inc (Ticker: GNVC), holds 8.62K shares in Merck & Company (Ticker: MRK).
Willam Kelley's Trading History
| ASXCAsensus Surgical | Apr 26, 2019 | ― | Uninformative Buy | ― | $31.49K | |
| GNVCGenVec Inc | Sep 05, 2013 | ― | Uninformative Buy | ― | $543.07K | |
| MRKMerck & Company | Nov 05, 2009 | Director | Uninformative Buy | ― | $1.27M |
You May Also Like
Willam Kelley insider profile FAQ
What is the percentage of profitable transactions made by Willam Kelley?
The percentage of profitable transactions made by Willam Kelley is 50%.
What is the average return per transaction made by Willam Kelley?
The average return per transaction made by Willam Kelley is 273.50%.
What stocks does Willam Kelley hold?
Willam Kelley holds: MRK, GNVC, ASXC stocks.
What was Willam Kelley's most profitable transaction?
Willam Kelley’s most profitable transaction was an Informative Buy of ASXC stock on August 9, 2017. The return on the trade was 584.20%.
What is Willam Kelley's role in Merck & Company?
Willam Kelley's role in Merck & Company is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
